Back to top
Saratoga Advantage Tr Health & Biotechnology Port Cl A: (MF: SHPAX)
(NASDAQ Mutual Funds) As of May 3, 2024 08:00 PM ET
$19.31 USD
+0.13 (0.68%)
Zacks MF Rank
4-Sell of 5 4
Fund Description
The fund was incepted in July 1999 and is managed by UBS Global Asset Management (Americas) Inc. The fund seeks long-term capital growth. The fund invests at least 80% of its total assets in equity, equity related or debt securities of healthcare companies and biotechnology companies, regardless of their stock market value (or 'market capitalization'). The fund invests primarily in common stocks of companies located throughout the world. The fund distributes dividends and capital gains annually.
Load Information
| Ticker | Max Load % |
Deferred Load % |
Red. Fee % |
12B-1 Fee % |
Mgmt Fee % |
Expense Ratio % |
|
|---|---|---|---|---|---|---|---|
| Saratoga Health & Biotechnology A | SHPAX | 5.75 | NA | 0.00 | 0.40 | 1.25 | 2.82 |
Return Data
| Ticker | Nav | Inception Date | % yield | 1 year return | 2 year return | 3 year return | |
|---|---|---|---|---|---|---|---|
| Saratoga Adv Tr-Health & Biotech A | SHPAX | 19.31 | 8/31/1999 | 0.00 | 10.94 | 6.25 | 7.76 |
| Saratoga Adv Tr-Health & Biotech C | SHPCX | 13.24 | 1/18/2000 | 0.00 | 10.29 | 5.63 | 7.13 |
| Saratoga Adv Tr-Health & Biotech I | SBHIX | 23.33 | 1/28/2003 | 0.00 | 11.39 | 6.69 | 8.19 |
Investment Information
| Ticker | Minimum Initial Investment ($) | Minimum Subsequent Investment ($) | Minimum Initial IRA ($) | Dividend Frequency | |
|---|---|---|---|---|---|
| Saratoga Health & Biotechnology A | SHPAX | 250 | 0 | 0 | A |
Contact Information
| Family | Saratoga Capital Management |
| Address | 1101 Stewart Ave, Ste 207 Garden City, NJ 11530 |
| Phone | 800 807-3863 |